Expedition Therapeutics
PrivateLast Round
Series B
Aug 5, 2026
Est. Valuation
$650M
Total Funding Raised
$280M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Expedition Therapeutics is a biotechnology company developing novel therapies for serious inflammatory and respiratory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Expedition Therapeutics Comparables
Compare Expedition Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Coultreon Biopharma | 74% | |
| GSK plc | 72% | |
| Slate Medicines | 71% |
Expedition Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 5, 2026 | ||||
| Series A | Oct 9, 2025 |
Expedition Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Balyasny Asset Management L.P. | Series A, Series B |
| RA Capital Management | Series B |
| Lake Bleu Capital | Series A |
| Forbion | Series A, Series B |
| Logos Capital | Series A, Series B |
| Novo Holdings | Series B, Series A |
| BVF Partners L.P. | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2026
Grew 21% QoQ from 14 to 17 employees.
- Aug 22, 2026
Monthly visitors increased 47% MoM, reaching 2.3K.
Recent news
Latest coverage and updates
- hiresAug 5, 2026
Expedition Therapeutics Inc. hired Brett Zbar as Board of Directors on Aug 6th '26.
- is_developingAug 5, 2026
Expedition Therapeutics Inc. is developing novel oral small molecule therapies for inflammatory and respiratory diseases on Aug 5th '26.
- receives_financingAug 5, 2026
Expedition Therapeutics Inc. received financing of $115M in Series B on Aug 5th '26.
Expedition Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Expedition Therapeutics's valuation, stock price, and market status.
Is Expedition Therapeutics a public or private company?
Expedition Therapeutics is a private company.
What is the current stock price of Expedition Therapeutics?
Expedition Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Expedition Therapeutics worth (valuation)?
Expedition Therapeutics's valuation is estimated at $650.0M based on funding round data.
Can I buy Expedition Therapeutics stock?
Expedition Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Expedition Therapeutics's last funding round?
Expedition Therapeutics's most recent funding round was Series A on October 9, 2025.
Who are the main investors in Expedition Therapeutics?
Key investors in Expedition Therapeutics include Novo Holdings, Sofinnova Investments.
Will Expedition Therapeutics IPO soon?
No public IPO plans have been announced for Expedition Therapeutics.
How can I track Expedition Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Expedition Therapeutics's secondary market activity and sign up for updates.